{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T09:53:35Z","timestamp":1789638815962,"version":"4.0.0"},"reference-count":50,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,11,29]],"date-time":"2021-11-29T00:00:00Z","timestamp":1638144000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004359","name":"Swedish Research Council","doi-asserted-by":"publisher","award":["2015-05015"],"award-info":[{"award-number":["2015-05015"]}],"id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2022,1]]},"DOI":"10.1016\/j.vaccine.2021.11.063","type":"journal-article","created":{"date-parts":[[2021,12,17]],"date-time":"2021-12-17T21:38:51Z","timestamp":1639777131000},"page":"673-681","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Modelling varicella vaccination \u2013 What does a lack of surge in herpes zoster incidence tell us about exogenous boosting?"],"prefix":"10.1016","volume":"40","author":[{"given":"Katarina","family":"Widgren","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"GianPaolo Scalia","family":"Tomba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ka Yin","family":"Leung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johan","family":"Giesecke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"45","key":"10.1016\/j.vaccine.2021.11.063_b0005","doi-asserted-by":"crossref","first-page":"7866","DOI":"10.1016\/j.vaccine.2007.07.036","article-title":"The comparative sero-epidemiology of varicella zoster virus in 11 countries in the European region","volume":"25","author":"Nardone","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2021.11.063_b0010","series-title":"Vaccines","first-page":"1145","article-title":"Varicella Vaccines","author":"Gershon","year":"2018"},{"key":"10.1016\/j.vaccine.2021.11.063_b0015","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1186\/1471-2334-13-170","article-title":"Similar herpes zoster incidence across Europe: results from a systematic literature review","volume":"13","author":"Pinchinat","year":"2013","journal-title":"BMC Infect Dis"},{"issue":"1","key":"10.1016\/j.vaccine.2021.11.063_b0020","first-page":"9","article-title":"The Nature of Herpes Zoster: A Long-Term Study and a New Hypothesis","volume":"58","author":"Hope-Simpson","year":"1965","journal-title":"Proc R Soc Med"},{"issue":"5","key":"10.1016\/j.vaccine.2021.11.063_b0025","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/S0190-9622(98)70207-5","article-title":"Lasting immunity to varicella in doctors study (L.I.V.I.D. study)","volume":"38","author":"Solomon","year":"1998","journal-title":"J Am Acad Dermatol"},{"issue":"9334","key":"10.1016\/j.vaccine.2021.11.063_b0030","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1016\/S0140-6736(02)09837-9","article-title":"Contacts with varicella or with children and protection against herpes zoster in adults: a case-control study","volume":"360","author":"Thomas","year":"2002","journal-title":"Lancet"},{"issue":"19-20","key":"10.1016\/j.vaccine.2021.11.063_b0035","doi-asserted-by":"crossref","first-page":"2500","DOI":"10.1016\/S0264-410X(02)00180-9","article-title":"Exposure to varicella boosts immunity to herpes-zoster: implications for mass vaccination against chickenpox","volume":"20","author":"Brisson","year":"2002","journal-title":"Vaccine"},{"issue":"44","key":"10.1016\/j.vaccine.2021.11.063_b0040","doi-asserted-by":"crossref","first-page":"7602","DOI":"10.1016\/j.vaccine.2011.08.023","article-title":"Contacts with children and young people and adult risk of suffering herpes zoster","volume":"29","author":"Salleras","year":"2011","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.vaccine.2021.11.063_b0045","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1093\/infdis\/148.2.200","article-title":"Immunologic evidence of reinfection with varicella-zoster virus","volume":"148","author":"Arvin","year":"1983","journal-title":"J Infect Dis"},{"issue":"2","key":"10.1016\/j.vaccine.2021.11.063_b0050","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1089\/vim.2010.0031","article-title":"Exploring the impact of exposure to primary varicella in children on varicella-zoster virus immunity of parents","volume":"24","author":"Ogunjimi","year":"2011","journal-title":"Viral Immunol"},{"issue":"3","key":"10.1016\/j.vaccine.2021.11.063_b0055","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1128\/CVI.00818-13","article-title":"Influence of frequent infectious exposures on general and varicella-zoster virus-specific immune responses in pediatricians","volume":"21","author":"Ogunjimi","year":"2014","journal-title":"Clin Vaccine Immunol"},{"issue":"8","key":"10.1016\/j.vaccine.2021.11.063_b0060","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1093\/aje\/kwv240","article-title":"The Epidemiology of Herpes Zoster After Varicella Immunization Under Different Biological Hypotheses: Perspectives From Mathematical Modeling","volume":"183","author":"Guzzetta","year":"2016","journal-title":"Am J Epidemiol"},{"issue":"3","key":"10.1016\/j.vaccine.2021.11.063_b0065","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1017\/S0950268800004714","article-title":"Modelling the impact of immunization on the epidemiology of varicella zoster virus","volume":"125","author":"Brisson","year":"2000","journal-title":"Epidemiol Infect"},{"issue":"19","key":"10.1016\/j.vaccine.2021.11.063_b0070","doi-asserted-by":"crossref","first-page":"3385","DOI":"10.1016\/j.vaccine.2010.02.079","article-title":"Modeling the impact of one- and two-dose varicella vaccination on the epidemiology of varicella and zoster","volume":"28","author":"Brisson","year":"2010","journal-title":"Vaccine"},{"issue":"13","key":"10.1016\/j.vaccine.2021.11.063_b0075","doi-asserted-by":"crossref","first-page":"2411","DOI":"10.1016\/j.vaccine.2011.01.037","article-title":"Modelling the impact of a combined varicella and zoster vaccination programme on the epidemiology of varicella zoster virus in England","volume":"29","author":"van Hoek","year":"2011","journal-title":"Vaccine"},{"issue":"4","key":"10.1016\/j.vaccine.2021.11.063_b0080","doi-asserted-by":"crossref","first-page":"812","DOI":"10.4161\/hv.23334","article-title":"Childhood varicella-zoster virus vaccination in Belgium: cost-effective only in the long run or without exogenous boosting?","volume":"9","author":"Bilcke","year":"2013","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.vaccine.2021.11.063_b0085","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/21645515.2015.1135279","article-title":"Current and future effects of varicella and herpes zoster vaccination in Germany - Insights from a mathematical model in a country with universal varicella vaccination","author":"Horn","year":"2016","journal-title":"Hum Vaccin Immunother"},{"issue":"10","key":"10.1016\/j.vaccine.2021.11.063_b0090","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1093\/aje\/kws370","article-title":"Hope-Simpson's progressive immunity hypothesis as a possible explanation for herpes zoster incidence data","volume":"177","author":"Guzzetta","year":"2013","journal-title":"Am J Epidemiol"},{"issue":"5","key":"10.1016\/j.vaccine.2021.11.063_b0095","doi-asserted-by":"crossref","first-page":"e0176845","DOI":"10.1371\/journal.pone.0176845","article-title":"The natural history of varicella zoster virus infection in Norway: Further insights on exogenous boosting and progressive immunity to herpes zoster","volume":"12","author":"Marangi","year":"2017","journal-title":"PLoS One"},{"issue":"10","key":"10.1016\/j.vaccine.2021.11.063_b0100","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1016\/j.ebiom.2015.08.017","article-title":"Distribution of Health Effects and Cost-effectiveness of Varicella Vaccination are Shaped by the Impact on Herpes Zoster","volume":"2","author":"van Lier","year":"2015","journal-title":"EBioMedicine"},{"issue":"1","key":"10.1016\/j.vaccine.2021.11.063_b0105","doi-asserted-by":"crossref","DOI":"10.1186\/s12916-018-1094-7","article-title":"The impact of demographic changes, exogenous boosting and new vaccination policies on varicella and herpes zoster in Italy: a modelling and cost-effectiveness study","volume":"16","author":"Melegaro","year":"2018","journal-title":"BMC Med"},{"issue":"8","key":"10.1016\/j.vaccine.2021.11.063_b0110","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1016\/j.vaccine.2018.01.038","article-title":"Modeling the impact of combined vaccination programs against varicella and herpes zoster in Norway","volume":"36","author":"Marchetti","year":"2018","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2021.11.063_b0115","doi-asserted-by":"crossref","first-page":"e5012","DOI":"10.7717\/peerj.5012","article-title":"Evaluation of the effect of chickenpox vaccination on shingles epidemiology using agent-based modeling","volume":"6","author":"Rafferty","year":"2018","journal-title":"PeerJ"},{"issue":"4","key":"10.1016\/j.vaccine.2021.11.063_b0120","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1017\/S0950268809990768","article-title":"Modelling the impact of varicella vaccination on varicella and zoster","volume":"138","author":"Karhunen","year":"2010","journal-title":"Epidemiol Infect"},{"issue":"11","key":"10.1016\/j.vaccine.2021.11.063_b0125","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1080\/14760584.2018.1538801","article-title":"Understanding the role of exogenous boosting in modeling varicella vaccination","volume":"17","author":"Talbird","year":"2018","journal-title":"Expert Rev Vaccines"},{"issue":"6","key":"10.1016\/j.vaccine.2021.11.063_b0130","doi-asserted-by":"crossref","first-page":"e004833","DOI":"10.1136\/bmjopen-2014-004833","article-title":"Systematic review of incidence and complications of herpes zoster: towards a global perspective","volume":"4","author":"Kawai","year":"2014","journal-title":"BMJ Open"},{"issue":"2","key":"10.1016\/j.vaccine.2021.11.063_b0135","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1093\/cid\/ciw296","article-title":"Increasing Incidence of Herpes Zoster Over a 60-year Period From a Population-based Study","volume":"63","author":"Kawai","year":"2016","journal-title":"Clin Infect Dis"},{"issue":"6","key":"10.1016\/j.vaccine.2021.11.063_b0140","doi-asserted-by":"crossref","first-page":"e66485","DOI":"10.1371\/journal.pone.0066485","article-title":"Herpes Zoster Risk Reduction through Exposure to Chickenpox Patients: A Systematic Multidisciplinary Review","volume":"8","author":"Ogunjimi","year":"2013","journal-title":"PLoS ONE"},{"key":"10.1016\/j.vaccine.2021.11.063_b0145","article-title":"Systematic review and meta-analysis of chickenpox vaccination and risk of herpes zoster: a quantitative view on the \u201cexogenous boosting hypothesis\u201d","author":"Harder","year":"2018","journal-title":"Clin Infect Dis"},{"issue":"8","key":"10.1016\/j.vaccine.2021.11.063_b0150","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1080\/14760584.2019.1646129","article-title":"Do varicella vaccination programs change the epidemiology of herpes zoster? A comprehensive review, with focus on the United States","volume":"18","author":"Harpaz","year":"2019","journal-title":"Expert Rev Vaccines"},{"issue":"1","key":"10.1016\/j.vaccine.2021.11.063_b0155","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1093\/infdis\/jit143","article-title":"Waning of maternal antibodies against measles, mumps, rubella, and varicella in communities with contrasting vaccination coverage","volume":"208","author":"Waaijenborg","year":"2013","journal-title":"J Infect Dis"},{"issue":"1","key":"10.1016\/j.vaccine.2021.11.063_b0160","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.mbs.2013.07.013","article-title":"Quantifying the re-exposure process to an infectious agent. Measles and varicella as examples","volume":"245","author":"Scalia Tomba","year":"2013","journal-title":"Math Biosci"},{"key":"10.1016\/j.vaccine.2021.11.063_b0165","article-title":"Risk of herpes zoster after exposure to varicella to explore the exogenous boosting hypothesis: self controlled case series study using UK electronic healthcare data","volume":"368","author":"Forbes","year":"2020","journal-title":"BMJ"},{"issue":"4","key":"10.1016\/j.vaccine.2021.11.063_b0170","doi-asserted-by":"crossref","first-page":"e60732","DOI":"10.1371\/journal.pone.0060732","article-title":"Perspectives on the impact of varicella immunization on herpes zoster. A model-based evaluation from three European countries","volume":"8","author":"Poletti","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.vaccine.2021.11.063_b9000","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.ijid.2021.08.012","article-title":"Severe chickenpox disease and seroprevalence in Sweden \u2013 implications for general vaccination","volume":"111","author":"Widgren","year":"2021","journal-title":"International Journal of Infectious Diseases"},{"key":"10.1016\/j.vaccine.2021.11.063_b0175","doi-asserted-by":"crossref","unstructured":"Hens N, Shkedy Z, Aerts M, Faes C, Van Damme P, Beutels P. Modeling Infectious Disease Parameters Based on Serological and Social Contact Data -A Modern Statistical Perspective: Springer-Verlag New York; 2012.","DOI":"10.1007\/978-1-4614-4072-7"},{"key":"10.1016\/j.vaccine.2021.11.063_b0180","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1186\/s12879-015-1170-y","article-title":"Incidence of herpes zoster and associated events including stroke\u2013a population-based cohort study","volume":"15","author":"Sundstrom","year":"2015","journal-title":"BMC Infect Dis"},{"issue":"9","key":"10.1016\/j.vaccine.2021.11.063_b0185","doi-asserted-by":"crossref","first-page":"e1002673","DOI":"10.1371\/journal.pcbi.1002673","article-title":"Inferring the structure of social contacts from demographic data in the analysis of infectious diseases spread","volume":"8","author":"Fumanelli","year":"2012","journal-title":"PLoS Comput Biol"},{"issue":"10","key":"10.1016\/j.vaccine.2021.11.063_b0190","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1097\/INF.0000000000001249","article-title":"Update on Incidence of Herpes Zoster Among Children and Adolescents After Implementation of Varicella Vaccination, Antelope Valley, CA, 2000 to 2010","volume":"35","author":"Civen","year":"2016","journal-title":"Pediatr Infect Dis J"},{"issue":"suppl 2","key":"10.1016\/j.vaccine.2021.11.063_b0195","doi-asserted-by":"crossref","first-page":"S75","DOI":"10.1093\/infdis\/jiy279","article-title":"Molecular Genetic Insights Into Varicella Zoster Virus (VZV), the vOka Vaccine Strain, and the Pathogenesis of Latency and Reactivation","volume":"218","author":"Breuer","year":"2018","journal-title":"J Infect Dis"},{"issue":"2","key":"10.1016\/j.vaccine.2021.11.063_b0200","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1093\/cid\/ciy954","article-title":"The Epidemiology of Herpes Zoster in the United States During the Era of Varicella and Herpes Zoster Vaccines: Changing Patterns Among Children","volume":"69","author":"Harpaz","year":"2019","journal-title":"Clin Infect Dis"},{"issue":"2","key":"10.1016\/j.vaccine.2021.11.063_b0205","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1093\/cid\/ciy953","article-title":"The Epidemiology of Herpes Zoster in the United States During the Era of Varicella and Herpes Zoster Vaccines: Changing Patterns Among Older Adults","volume":"69","author":"Harpaz","year":"2019","journal-title":"Clin Infect Dis"},{"issue":"suppl 2","key":"10.1016\/j.vaccine.2021.11.063_b0210","doi-asserted-by":"crossref","first-page":"S57","DOI":"10.1093\/infdis\/jiy418","article-title":"Point-Counterpoint: The Hope-Simpson Hypothesis and Its Implications Regarding an Effect of Routine Varicella Vaccination on Herpes Zoster Incidence","volume":"218","author":"Harpaz","year":"2018","journal-title":"J Infect Dis"},{"issue":"1804","key":"10.1016\/j.vaccine.2021.11.063_b0215","first-page":"20142509","article-title":"The impact of demographic changes on the epidemiology of herpes zoster: Spain as a case study","volume":"282","author":"Marziano","year":"2015","journal-title":"Proc Biol Sci"},{"issue":"1","key":"10.1016\/j.vaccine.2021.11.063_b0220","doi-asserted-by":"crossref","DOI":"10.1186\/s12879-019-3759-z","article-title":"The impact of childhood varicella vaccination on the incidence of herpes zoster in the general population: modelling the effect of exogenous and endogenous varicella-zoster virus immunity boosting","volume":"19","author":"Sauboin","year":"2019","journal-title":"BMC Infect Dis"},{"issue":"11","key":"10.1016\/j.vaccine.2021.11.063_b0225","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1093\/infdis\/jit405","article-title":"Incidence and clinical characteristics of herpes zoster among children in the varicella vaccine era, 2005\u20132009","volume":"208","author":"Weinmann","year":"2013","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2021.11.063_b0230","doi-asserted-by":"crossref","unstructured":"Gilden D, Nagel M, Cohrs R, Mahalingam R, Baird N. Varicella Zoster Virus in the Nervous System. F1000Res 2015;4.","DOI":"10.12688\/f1000research.7153.1"},{"issue":"3","key":"10.1016\/j.vaccine.2021.11.063_b0235","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.jinf.2015.06.004","article-title":"Varicella-zoster virus infections of the central nervous system - Prognosis, diagnostics and treatment","volume":"71","author":"Grahn","year":"2015","journal-title":"J Infect"},{"issue":"3","key":"10.1016\/j.vaccine.2021.11.063_b0240","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1097\/QCO.0000000000000258","article-title":"Varicella zoster virus and giant cell arteritis","volume":"29","author":"Gilden","year":"2016","journal-title":"Curr Opin Infect Dis"},{"issue":"1","key":"10.1016\/j.vaccine.2021.11.063_b0245","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-017-01024-8","article-title":"Multidisciplinary study of the secondary immune response in grandparents re-exposed to chickenpox","volume":"7","author":"Ogunjimi","year":"2017","journal-title":"Sci Rep"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X21015371?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X21015371?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T11:06:21Z","timestamp":1759403181000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X21015371"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1]]},"references-count":50,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022,1]]}},"alternative-id":["S0264410X21015371"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2021.11.063","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2022,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Modelling varicella vaccination \u2013 What does a lack of surge in herpes zoster incidence tell us about exogenous boosting?","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2021.11.063","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}